Details for New Drug Application (NDA): 217970
✉ Email this page to a colleague
The generic ingredient in NITROGLYCERIN is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 217970
Tradename: | NITROGLYCERIN |
Applicant: | Mankind Pharma |
Ingredient: | nitroglycerin |
Patents: | 0 |
Pharmacology for NDA: 217970
Physiological Effect | Vasodilation |
Medical Subject Heading (MeSH) Categories for 217970
Suppliers and Packaging for NDA: 217970
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 217970 | ANDA | Lifestar Pharma LLC | 70756-013 | 70756-013-11 | 1 BOTTLE in 1 CARTON (70756-013-11) / 100 TABLET in 1 BOTTLE |
NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 217970 | ANDA | Lifestar Pharma LLC | 70756-014 | 70756-014-02 | 4 BOTTLE in 1 CARTON (70756-014-02) / 25 TABLET in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | 0.3MG | ||||
Approval Date: | Dec 5, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | 0.4MG | ||||
Approval Date: | Dec 5, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;SUBLINGUAL | Strength | 0.6MG | ||||
Approval Date: | Dec 5, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription